GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abattis Bioceuticals Corp (OTCPK:ATTBF) » Definitions » Shares Buyback Ratio %

Abattis Bioceuticals (Abattis Bioceuticals) Shares Buyback Ratio % : -12.33 (As of Jun. 07, 2024)


View and export this data going back to . Start your Free Trial

What is Abattis Bioceuticals Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Abattis Bioceuticals's current shares buyback ratio was -12.33%.


Abattis Bioceuticals Shares Buyback Ratio % Historical Data

The historical data trend for Abattis Bioceuticals's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abattis Bioceuticals Shares Buyback Ratio % Chart

Abattis Bioceuticals Annual Data
Trend Sep10 Sep11 Sep12 Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19
Shares Buyback Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -18.29 -43.24 -50.74 -156.50 -12.33

Abattis Bioceuticals Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.65 -12.14 -0.17 - -

Abattis Bioceuticals Shares Buyback Ratio % Calculation

Abattis Bioceuticals's Shares Buyback Ratio for the fiscal year that ended in Sep. 2019 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Sep. 2018 ) - Shares Outstanding (EOP) (A: Sep. 2019 )) / Shares Outstanding (EOP) (A: Sep. 2018 )
=(425.362 - 477.804) / 425.362
=-12.33%

Abattis Bioceuticals's Shares Buyback Ratio for the quarter that ended in Sep. 2019 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Jun. 2019 ) - Shares Outstanding (EOP) (A: Sep. 2019 )) / Shares Outstanding (EOP) (A: Jun. 2019 )
=(477.804 - 477.804) / 477.804
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abattis Bioceuticals Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Abattis Bioceuticals's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Abattis Bioceuticals (Abattis Bioceuticals) Business Description

Traded in Other Exchanges
N/A
Address
1200 - 625 Howe Street, Vancouver, BC, CAN, V6C 2M6
Abattis Bioceuticals Corp is a Canadian life science and biotechnology company focuses on aggregating, integrating and investing in agricultural technologies and biotechnology services for the legal cannabis industry. It is primarily engaged in producing, licensing and marketing proprietary ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The company is also engaged in growing, extraction, testing, propagation and online distribution.